Loading...
Novartis AG
NVS•NYSE
Healthcare
Drug Manufacturers - General
$121.01
$1.00(0.83%)
Novartis AG (NVS) Financial Performance & Statements
Review Novartis AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
10.85%
↑ 10.85%
Operating Income Growth
48.88%
↑ 48.88%
Net Income Growth
-19.59%
↓ 19.59%
Operating Cash Flow Growth
21.86%
↑ 21.86%
Operating Margin
29.79%
↑ 29.79%
Gross Margin
75.40%
↑ 75.40%
Net Profit Margin
24.33%
↑ 24.33%
ROE
30.71%
↑ 30.71%
ROIC
23.05%
↑ 23.05%
Novartis AG (NVS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Novartis AG stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $13.56B | $13.17B | $12.87B | $12.12B |
| Cost of Revenue | $3.32B | $3.23B | $3.17B | $3.10B |
| Gross Profit | $10.23B | $9.94B | $9.70B | $9.02B |
| Gross Profit Ratio | $0.75 | $0.75 | $0.75 | $0.74 |
| R&D Expenses | $2.84B | $2.39B | $2.37B | $2.42B |
| SG&A Expenses | $3.50B | $3.13B | $3.09B | $2.84B |
| Operating Expenses | $6.70B | $6.31B | $5.68B | $5.65B |
| Total Costs & Expenses | $10.03B | $9.54B | $8.86B | $8.75B |
| Interest Income | $291.00M | $26.00M | $246.00M | $6.00M |
| Interest Expense | $275.00M | $264.00M | $246.00M | $221.00M |
| Depreciation & Amortization | $1.63B | $1.97B | $1.16B | $1.31B |
| EBITDA | $5.19B | $5.61B | $5.25B | $4.66B |
| EBITDA Ratio | $0.38 | $0.43 | $0.41 | $0.38 |
| Operating Income | $3.53B | $3.63B | $4.01B | $3.37B |
| Operating Income Ratio | $0.26 | $0.28 | $0.31 | $0.28 |
| Other Income/Expenses (Net) | -$245.00M | -$242.00M | -$173.00M | -$244.00M |
| Income Before Tax | $3.29B | $3.38B | $3.84B | $3.13B |
| Income Before Tax Ratio | $0.24 | $0.26 | $0.30 | $0.26 |
| Income Tax Expense | $465.00M | $200.00M | $595.00M | $441.00M |
| Net Income | $2.82B | $3.19B | $3.25B | $2.69B |
| Net Income Ratio | $0.21 | $0.24 | $0.25 | $0.22 |
| EPS | $1.40 | $1.58 | $1.60 | $1.31 |
| Diluted EPS | $1.39 | $1.57 | $1.59 | $1.31 |
| Weighted Avg Shares Outstanding | $2.01B | $2.01B | $2.04B | $2.04B |
| Weighted Avg Shares Outstanding (Diluted) | $2.03B | $2.03B | $2.05B | $2.06B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan